There is uncertainty surrounding the renaming of polycystic ovary syndrome, with reports that it has been officially renamed polyendocrine metabolic ovarian syndrome, while also being described as under discussion. The condition, also known as pcos, is being highlighted by the royal australian college of general practitioners. Guidelines and management of the condition are being explored to improve support for affected women.